Stopping Ozempic may raise heart attack and stroke risk
Monday, September 21, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them. (via Science Daily)
Read the Full StoryThis article will expire in 28 days.
In the News...
View All Recent News
- Coffee doesn’t have to keep you awake to disrupt your sleep
- This emerging treatment could help people avoid knee replacement surgery
- Brain scans reveal a possible cause of long COVID fatigue and brain fog
- Stopping Ozempic may raise heart attack and stroke risk
- Stem cells reverse stroke damage and restore movement in mice
- Stanford scientists discover the human brain may actually be two separate organs
- Chronic stress may be quietly reshaping your heart
- Scientists create a needle-thin brain implant that can do three jobs at once
- Millions take calcium and vitamin D for bone health. A major review finds little benefit
- Ancient DNA reveals how plague kept returning for 400 years after the Black Death
- 8 common food additives linked to high blood pressure and heart disease
- Hidden gut defect that may explain why IBD keeps coming back
- Scientists solve a 50-year mystery and discover a new human blood group
- Scientists find that “perfect” systems may be surprisingly fragile
- A deadly ebola relative is surging after years in the shadows
- Scientists discover cells that cheat death and rebuild damaged tissue
- Ozempic can change your body. Can it change your life?
- These blood thinners may have an unexpected benefit for Alzheimer’s patients
- Scientists restore a brain protein and reverse signs of aging in mice
- This popular fermented food may help flush nanoplastics from the body